NVST Add to watchlist $27.03 0.35 (-1.28%) Last updated: Apr 16, 2026 00:51
52-Week Range
$27.03
$14.72 $27.03 $30.42

Fundamentals Overview

Envista Holdings Corp is near the high of its 52-week range with premium valuation, trading relatively flat today.

Valuation premium

P/E 95.5 PEG 0.92 P/B 1.43 P/S 1.63

Intrinsic value (DCF)

+80.1% upside vs price

Profitability

Net margin 1.7%

Risk (Beta)

0.99 — in line vol

Earnings & growth

EPS $0.28 Rev +12% Profit +208.6% vs prior qtr

BullzEye Analysis

Our composite tilts Buy on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.

Composite Signal

Sell
Buy
Buy — 77% confidence Risk: Moderate Volatility — Beta 0.99. Diversify and only invest what you can afford to lose.

Supporting (Buy):

DCF +80.1% upside vs price · Analyst grade: B · Sentiment improving (2 upgrades) · 3M vs S&P 500: +14.9% · 3M vs Healthcare sector: +21.7%

Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.

Key Stats

Market Cap
$4.43B
P/E (TTM)
95.47
EPS (TTM)
$0.28
Dividend Yield
N/A
52-Week Range
$14.72 - $30.42
Volume vs Avg
N/A
Beta
0.99

About

Envista Holdings Corp. manufactures and markets dental products for diagnosing, treating and preventing dental conditions. The company is headquartered in Brea, California and currently employs 12,800 full-time employees. The firm provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone. The firm operates through two segments: Specialty Products & Technologies, and Equipment & Consumables. Its Specialty Products & Technologies seg...
Sector: Healthcare
Headquarters: US
Employees: 12,300
IPO Date: Sep 2019
Beta: 0.99 (Less volatile than market)

Ratings & Grades at a Glance

Overall rating: B. Recent institutional grades: majority upgrades. Current institutional positions: Buy: 4, Equal Weight: 5, Hold: 2, Neutral: 14, Outperform: 3, Overweight: 1, Underperform: 1.

Financial story & AI narrative

Open this tab to load the financial story.

Valuation & Ratios

Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.

DCF vs price: DCF estimate is $48.68; current price is $27.03. That’s a +80.1% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.

Metric Value
Valuation
P/E (TTM) 95.47
DCF value (model) $48.68 (80.1% upside)
PEG (TTM) 0.92
P/B (TTM) 1.43
P/S (TTM) 1.63
P/FCF (TTM) 19.23
Liquidity & enterprise
Current Ratio (TTM) 2.38
Quick Ratio (TTM) 2.04
Cash Ratio (TTM) 1.42
Profitability
ROE (TTM) N/A
ROA (TTM) N/A
Revenue growth (YoY) N/A
Net margin (TTM) 1.73%
Gross margin (TTM) 54.95%
Operating margin (TTM) 8.47%
Debt to equity (TTM) N/A

Latest News

News loads when you open this tab.

Price Target, Ratings & Grades

Analyst price targets, consensus, rating snapshot, and institutional grades for NVST.

Analyst Sentiment at a Glance

B Sentiment Improving
Buy 4Equal Weight 5Hold 2Neutral 14Outperform 3Overweight 1Underperform 1
2 upgrades, 0 downgrades
Price Target Consensus
Current $27.03
Median $25.00
Consensus $27.00
Low consensus $19.00
High consensus $35.00

Stock Grades (Institutions)

Institution Action Previous Grade New Grade Date
Evercore ISI Group maintain Outperform Outperform 2026-04-08
Barclays maintain Overweight Overweight 2026-02-11
Mizuho maintain Neutral Neutral 2026-02-10
Stifel maintain Buy Buy 2026-02-06
JP Morgan maintain Neutral Neutral 2026-02-06
Wells Fargo maintain Equal Weight Equal Weight 2026-02-06
Piper Sandler maintain Neutral Neutral 2026-02-06
Stifel maintain Buy Buy 2026-02-04
UBS maintain Neutral Neutral 2026-02-03
Piper Sandler maintain Neutral Neutral 2026-01-30
Mizuho upgrade Underperform Neutral 2026-01-20
JP Morgan maintain Neutral Neutral 2025-12-16
Wells Fargo maintain Equal Weight Equal Weight 2025-08-01
Piper Sandler maintain Neutral Neutral 2025-08-01
Morgan Stanley maintain Equal Weight Equal Weight 2025-08-01
Stifel maintain Buy Buy 2025-08-01
Mizuho maintain Underperform Underperform 2025-08-01
UBS maintain Neutral Neutral 2025-07-29
Evercore ISI Group maintain Outperform Outperform 2025-07-09
Baird upgrade Neutral Outperform 2025-05-27
UBS maintain Neutral Neutral 2025-05-05
Baird maintain Neutral Neutral 2025-05-02
Piper Sandler maintain Neutral Neutral 2025-04-30
B of A Securities maintain Buy Buy 2025-04-29
UBS maintain Neutral Neutral 2025-03-10
Morgan Stanley maintain Equal Weight Equal Weight 2025-03-06
JP Morgan maintain Neutral Neutral 2025-03-06
Needham maintain Hold Hold 2025-03-06
Needham maintain Hold Hold 2025-02-25
Wells Fargo maintain Equal Weight Equal Weight 2025-02-06